Basics Hutchison China MediTech Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases. IPO Date: March 17, 2016 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $2.44B Activated in VL: True Average Daily Range Avg Daily Range: $0.43 | 1.95% Avg Daily Range (30 D): $0.11 | 0.77% Avg Daily Range (90 D): $0.15 | 0.95% Institutional Daily Volume Avg Daily Volume: .16M Avg Daily Volume (30 D): .03M Avg Daily Volume (90 D): .04M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 64 Institutional Trades Total Inst.Trades: 923 Avg Inst. Trade: $1.84M Avg Inst. Trade (30 D): $1.6M Avg Inst. Trade (90 D): $1.6M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.1M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $.53M Avg Closing Volume: 88.71K     News Dec 4, 2025 @ 6:00 PM Acute Myeloid Leukemia Clinical Trial Pipeline App... Source: Delveinsight Nov 27, 2025 @ 12:00 AM HUTCHMED Highlights Clinical Data to be Presented ... Source: Hutchmed Nov 3, 2025 @ 12:00 AM HUTCHMED Highlights Pipeline and Business Progress... Source: Hutchmed Oct 31, 2025 @ 12:00 AM International companies to host live webcasts at D... Source: Deutsche Bank Ag Aug 25, 2025 @ 12:20 AM HUTCHMED Announces Appointment of Acting Chief Exe... Source: Hutchmed Splits Apr 20, 2009:   1:50